OptiNose (NASDAQ: OPTN) reported Q3 EPS of $0.00, $0.05 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $20.4 million versus the consensus estimate of $22.95 million.

The Company expects XHANCE net revenues for the full year of 2024 to be between $75.0 to $79.0 million. Previously the Company expected XHANCE net revenues for the full year of 2024 to be between $85.0 to $90.0 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.